84 related articles for article (PubMed ID: 221106)
1. Cyclic adenosine 3':5'-monophosphate and protein kinase activity in insulin-dependent and -independent mammary tumors.
Shafie SM; Cho-Chung YS; Gullino PM
Cancer Res; 1979 Jul; 39(7 Pt 1):2501-4. PubMed ID: 221106
[TBL] [Abstract][Full Text] [Related]
2. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
Bodwin JS; Clair T; Cho-Chung YS
Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938
[TBL] [Abstract][Full Text] [Related]
3. Regression of hormone-dependent mammary tumors in Sprague-Dawley rats as a result of tamoxifen or pharmacologic doses of 17 beta-estradiol: cyclic adenosine 3',5'-monophosphate-mediated events.
Bodwin JS; Hirayama PH; Rego JA; Cho-Chung YS
J Natl Cancer Inst; 1981 Feb; 66(2):321-6. PubMed ID: 6256577
[TBL] [Abstract][Full Text] [Related]
4. Anticarcinogenic effect of N6,O2'-dibutyryl cyclic adenosine 3':5'-monophosphate on 7,12-dimethylbenz(a)anthracene mammary tumor induction in the rat and its relationship to cyclic adenosine 3':5'-monophosphate metabolism and protein kinase.
Cho-Chung YS; Clair T; Shepheard C
Cancer Res; 1983 Jun; 43(6):2736-40. PubMed ID: 6303567
[TBL] [Abstract][Full Text] [Related]
5. Cyclic adenosine 3':5-monophosphate receptor proteins in hormone-dependent and -independent rat mammary tumors.
Cho-Chung YS; Clair T; Schwimmer M; Steinberg L; Rego J; Grantham F
Cancer Res; 1981 May; 41(5):1840-6. PubMed ID: 7214351
[TBL] [Abstract][Full Text] [Related]
6. Regulation of estrogen-binding capacity by insulin in 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Gibson SL; Hilf R
Cancer Res; 1980 Jul; 40(7):2343-8. PubMed ID: 6770998
[TBL] [Abstract][Full Text] [Related]
7. Concurrent changes in growth-related biochemical parameters during regression of hormone-dependent rat mammary tumors.
Foecking MK; Abou-Issa H; Webb TE; Minton JP
J Natl Cancer Inst; 1983 Oct; 71(4):773-8. PubMed ID: 6312151
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the cyclic adenosine 3':5'-monophosphate effector system in hormone-dependent and hormone-independent rat mammary carcinomas.
Ogreid D; Cho-Chung YS; Ekanger R; Vintermyr O; Haavik J; Døskeland SO
Cancer Res; 1987 May; 47(10):2576-82. PubMed ID: 3032409
[TBL] [Abstract][Full Text] [Related]
9. Levels of cyclic nucleotides in autotransplanted 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors during their growth and regression.
Lee C
J Natl Cancer Inst; 1980 Nov; 65(5):1029-32. PubMed ID: 6253705
[TBL] [Abstract][Full Text] [Related]
10. Relationship between insulin and estrogen binding to growth response in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
Shafie SM; Hilf R
Cancer Res; 1978 Mar; 38(3):759-64. PubMed ID: 414834
[TBL] [Abstract][Full Text] [Related]
11. Influence of hormonal alteration of host on estrogen-binding capacity in 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
Gibson SL; Hilf R
Cancer Res; 1976 Oct; 36(10):3736-41. PubMed ID: 133755
[TBL] [Abstract][Full Text] [Related]
12. Nucleolar accumulation of cyclic adenosine 3':5'-monophosphate receptor proteins during regression of MCF-7 human breast tumor.
Kapoor CL; Grantham F; Cho-Chung YS
Cancer Res; 1984 Aug; 44(8):3554-60. PubMed ID: 6331652
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid priming potentiates the induction of urokinase-type plasminogen activator by cyclic adenosine monophosphate in mouse mammary carcinoma cells.
Mira-y-Lopez R
J Cell Physiol; 1991 Apr; 147(1):46-54. PubMed ID: 1645361
[TBL] [Abstract][Full Text] [Related]
14. Arrest of hormone-dependent mammary cancer growth in vivo and in vitro by cholera toxin.
Cho-Chung YS; Clair T; Shepheard C; Berghoffer B
Cancer Res; 1983 Apr; 43(4):1473-6. PubMed ID: 6299521
[TBL] [Abstract][Full Text] [Related]
15. Prolactin binding to 7,12-dimethylbenz(a)anthracene-induced mammary tumors and liver in diabetic rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1977 Nov; 37(11):4070-4. PubMed ID: 409490
[TBL] [Abstract][Full Text] [Related]
16. Changes in cyclic adenosine 3':5'-monophosphate-dependent protein kinases during the progression of urethan-induced mouse lung tumors.
Butley MS; Stoner GD; Beer DG; Beer DS; Mason RJ; Malkinson AM
Cancer Res; 1985 Aug; 45(8):3677-85. PubMed ID: 2990675
[TBL] [Abstract][Full Text] [Related]
17. Hypothesis. Cyclic AMP and its receptor protein in tumor growth regulation in vivo.
Cho-Chung YS
J Cyclic Nucleotide Res; 1980; 6(3):163-77. PubMed ID: 6255017
[TBL] [Abstract][Full Text] [Related]
18. [The effect of estradiol on the activity of cAMP-dependent protein kinase in cells of estradiol-dependent tumors of the rat mammary gland. The role of a thermally stable protein inhibitor of cAMP-dependent protein kinase].
Nagibneva IN; Sidorkina OM; Morozova TM
Biokhimiia; 1989 Aug; 54(8):1379-85. PubMed ID: 2819108
[TBL] [Abstract][Full Text] [Related]
19. Effects of diabetes and sex steroid hormones on insulin receptor tyrosine kinase activity in R3230AC mammary adenocarcinomas.
Hilf R; Livingston JN; Crofton DH
Cancer Res; 1988 Jul; 48(13):3742-50. PubMed ID: 3288334
[TBL] [Abstract][Full Text] [Related]
20. Induction of the regulatory subunit of type I adenosine cyclic 3':5'-monophosphate-dependent protein kinase in differentiated N-18 mouse neuroblastoma cells.
Liu AY; Chan T; Chen KY
Cancer Res; 1981 Nov; 41(11 Pt 1):4579-87. PubMed ID: 6272981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
